Chenglong Liu
About
Chenglong Liu has authored 12 papers that have received a total of 274 indexed citations.
This includes 9 papers in Oncology, 7 papers in Molecular Biology and 5 papers in Immunology. The topics of these papers are Cancer Immunotherapy and Biomarkers (5 papers), Wnt/β-catenin signaling in development and cancer (4 papers) and Peptidase Inhibition and Analysis (3 papers). Chenglong Liu is often cited by papers focused on Cancer Immunotherapy and Biomarkers (5 papers), Wnt/β-catenin signaling in development and cancer (4 papers) and Peptidase Inhibition and Analysis (3 papers) and collaborates with scholars based in China, Germany and Japan. Chenglong Liu's co-authors include Di Zhu, Ker Yu, Lian Shen and Yonghui Wang and has published in prestigious journals such as Journal of Medicinal Chemistry, British Journal of Pharmacology and Molecular Pharmacology.
In The Last Decade
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Priscilla K. Cavanaugh Breakdown of academic impact, for papers by Tim Poston Breakdown of academic impact, for papers by S. Jordan Breakdown of academic impact, for papers by Supriya Jain Breakdown of academic impact, for papers by Scott Packer Breakdown of academic impact, for papers by Gerard Martin Breakdown of academic impact, for papers by Giorgia D. Ugarte Breakdown of academic impact, for papers by Gilda Silva